Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 10,534 shares at $25.01 ($263K) on 2018-03-08, disclosed to the SEC on 2018-03-12.
Open-market sale of $263k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.01 | 5,267 | $132K | 50.0% |
| 2 | $25.01 | 5,267 | $132K | 50.0% |
| Total | $25.01 avg | 10,534 | $263K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-22 | $536K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |